$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

$sfes Overview Financials Valuation SEC Filings Company Website

2018 Q4 Form 10-K Financial Statement

#000008611519000005 Filed on March 01, 2019

Income Statement

Concept	2018 Q4	2017 Q4	2017 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.600M	$3.900M	$3.800M
YoY Change	-33.33%	0.0%	-19.15%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.600M	$4.000M	$3.800M
YoY Change	-35.0%	2.56%	-19.15%
Operating Profit	-$2.618M	-$3.940M	-$3.758M
YoY Change	-33.55%	0.31%	-19.82%
Interest Expense	-$13.80M	-$14.80M	-$14.90M
YoY Change	-6.76%	-16.85%	-12.35%
% of Operating Profit
Other Income/Expense, Net	-$193.0K	-$120.0K	-$379.0K
YoY Change	60.83%	-287.5%	-84.24%
Pretax Income	-$16.62M	-$18.73M	-$18.65M
YoY Change	-11.24%	-13.7%	-22.57%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$16.62M	-$18.73M	-$18.65M
YoY Change	-11.24%	-13.7%	-22.57%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.81	-$0.91	-$0.91
Diluted Earnings Per Share	-$0.81	-$0.91	-$0.91
COMMON SHARES
Basic Shares Outstanding	20.65M shares	20.41M shares	20.46M shares
Diluted Shares Outstanding			20.46M shares

Balance Sheet

Concept	2018 Q4	2017 Q4	2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.70M	$25.25M	$39.72M
YoY Change	80.99%	-16.94%	-40.1%
Cash & Equivalents	$7.703M	$20.75M	$34.32M
Short-Term Investments	$38.00M	$4.500M	$5.400M
Other Short-Term Assets	$1.100M	$4.600M	$3.700M
YoY Change	-76.09%	119.05%	94.74%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$46.74M	$33.61M	$47.06M
YoY Change	39.06%	3.25%	-31.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$808.0K	$1.513M	$1.626M
YoY Change	-46.6%	-19.22%	-16.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$64.49M	$108.1M	$114.3M
YoY Change	-40.34%	-30.11%	-24.74%
Other Assets	$2.609M	$316.0K	$316.0K
YoY Change	725.63%	6.76%	6.76%
Total Long-Term Assets	$99.00M	$142.9M	$147.2M
YoY Change	-30.7%	-28.31%	-20.64%
TOTAL ASSETS
Total Short-Term Assets	$46.74M	$33.61M	$47.06M
Total Long-Term Assets	$99.00M	$142.9M	$147.2M
Total Assets	$145.7M	$176.5M	$194.3M
YoY Change	-17.41%	-23.88%	-23.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$165.0K	$155.0K	$171.0K
YoY Change	6.45%	10.71%	55.45%
Accrued Expenses	$2.182M	$1.851M	$2.495M
YoY Change	17.88%	-16.73%	-20.44%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$40.49M	$40.10M
YoY Change	-100.0%
Total Short-Term Liabilities	$32.94M	$45.81M	$45.66M
YoY Change	-28.1%	681.64%	601.89%
LONG-TERM LIABILITIES
Long-Term Debt	$43.00M	$45.30M	$44.90M
YoY Change	-5.08%	-13.88%	-13.82%
Other Long-Term Liabilities	$2.804M	$3.535M	$3.504M
YoY Change	-20.68%	-2.62%	-11.22%
Total Long-Term Liabilities	$2.804M	$3.535M	$3.504M
YoY Change	-20.68%	-2.62%	-11.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.94M	$45.81M	$45.66M
Total Long-Term Liabilities	$2.804M	$3.535M	$3.504M
Total Liabilities	$78.76M	$94.67M	$94.07M
YoY Change	-16.81%	52.56%	50.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$731.1M	-$715.5M	-$696.7M
YoY Change	2.18%	14.13%	15.13%
Common Stock	$813.1M	$814.7M	$817.2M
YoY Change	-0.2%	-0.43%	-0.35%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$15.00M	$17.31M	$20.12M
YoY Change	-13.33%	-17.82%	-14.25%
Treasury Stock Shares	914.0K shares	999.0K shares	1.169M shares
Shareholders Equity	$67.00M	$81.80M	$100.2M
YoY Change
Total Liabilities & Shareholders Equity	$145.7M	$176.5M	$194.3M
YoY Change	-17.41%	-23.88%	-23.43%

Cashflow Statement

Concept	2018 Q4	2017 Q4	2017 Q3
OPERATING ACTIVITIES
Net Income	-$16.62M	-$18.73M	-$18.65M
YoY Change	-11.24%	-13.7%	-22.57%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$7.400M	-$5.300M	-$4.100M
YoY Change	39.62%	15.22%	24.24%
INVESTING ACTIVITIES
Capital Expenditures		$0.00	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$12.50M	-$8.200M	-$7.000M
YoY Change	52.44%	-57.29%	-32.69%
Cash From Investing Activities	-$12.50M	-$8.200M	-$7.000M
YoY Change	52.44%	-57.95%	-32.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-16.50M	-100.0K	-2.700M
YoY Change	16400.0%		2600.0%
NET CHANGE
Cash From Operating Activities	-7.400M	-5.300M	-4.100M
Cash From Investing Activities	-12.50M	-8.200M	-7.000M
Cash From Financing Activities	-16.50M	-100.0K	-2.700M
Net Change In Cash	-36.40M	-13.60M	-13.80M
YoY Change	167.65%	-43.57%	0.0%
FREE CASH FLOW
Cash From Operating Activities	-$7.400M	-$5.300M	-$4.100M
Capital Expenditures		$0.00	$0.00
Free Cash Flow		-$5.300M	-$4.100M
YoY Change		23.26%	24.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Type DocumentType	10-K
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0000086115
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20652338	shares
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2018Q2	dei	Entity Public Float EntityPublicFloat	237111560	USD
CY2018	dei	Entity Registrant Name EntityRegistrantName	SAFEGUARD SCIENTIFICS INC
CY2018	dei	Entity Shell Company EntityShellCompany	false
CY2018	dei	Entity Small Business EntitySmallBusiness	true
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2018	dei	Trading Symbol TradingSymbol	SFE
CY2018Q4	sfe	Cash Liabilityfor Performance Based Units CashLiabilityforPerformanceBasedUnits	0	USD
CY2018	sfe	Debt Instrument Gain Lossfrom Covenant Liability DebtInstrumentGainLossfromCovenantLiability	-4500000	USD
CY2017Q4	sfe	Deferred Tax Asset Debt Repayment Feature DeferredTaxAssetDebtRepaymentFeature	0	USD
CY2018Q4	sfe	Deferred Tax Asset Debt Repayment Feature DeferredTaxAssetDebtRepaymentFeature	1312000	USD
CY2017Q4	sfe	Deferred Tax Asset Disallowed Interest Carryforwards DeferredTaxAssetDisallowedInterestCarryforwards	0	USD
CY2018Q4	sfe	Deferred Tax Asset Disallowed Interest Carryforwards DeferredTaxAssetDisallowedInterestCarryforwards	3831000	USD
CY2018Q4	sfe	Equity Method Investment Assets Exceed Carrying Value Of Investment EquityMethodInvestmentAssetsExceedCarryingValueOfInvestment	43000000	USD
CY2001Q4	sfe	Future Annual Payment To Chairman And Chief Executive Officer FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer	650000	USD
CY2017	sfe	Gain Lossfrom Observable Price Changes GainLossfromObservablePriceChanges	0	USD
CY2018	sfe	Gain Lossfrom Observable Price Changes GainLossfromObservablePriceChanges	1415000	USD
CY2018Q4	sfe	Impaired Loans Carrying Amount ImpairedLoansCarryingAmount	0	USD
CY2017Q4	sfe	Lineof Credit Facility Repayment Feature Current LineofCreditFacilityRepaymentFeatureCurrent	0	USD
CY2018Q4	sfe	Lineof Credit Facility Repayment Feature Current LineofCreditFacilityRepaymentFeatureCurrent	5060000	USD
CY2018	sfe	Loan Impairment Charge LoanImpairmentCharge	15700000	USD
CY2018Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Four NetOperatingLossCarryforwardsExpiringInYearFour	48848000	USD
CY2018Q4	sfe	Net Operating Loss Carryforwards Expiring In Year One NetOperatingLossCarryforwardsExpiringInYearOne	0	USD
CY2018Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Thereafter NetOperatingLossCarryforwardsExpiringInYearThereafter	229867000	USD
CY2018Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Three NetOperatingLossCarryforwardsExpiringInYearThree	3728000	USD
CY2018Q4	sfe	Net Operating Loss Carryforwards Expiring In Year Two NetOperatingLossCarryforwardsExpiringInYearTwo	0	USD
CY2017	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	318000	USD
CY2018	sfe	Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments	113000	USD
CY2018Q4	sfe	Partner Companies Not Consolidated In Financial Statements PartnerCompaniesNotConsolidatedInFinancialStatements	21	partner_company
CY2018Q1	sfe	Saleof Stock Individual Ownership Percent Maximum SaleofStockIndividualOwnershipPercentMaximum	0.0499
CY2018Q4	sfe	Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Award Vesting Types SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofAwardVestingTypes	2	vesting_type
CY2018	sfe	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit	82500000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	155000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	165000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1851000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2182000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-113000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	812536000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	810928000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	-826000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1138000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	966000	USD
CY2017Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	22506000	USD
CY2018Q4	us-gaap	Advances To Affiliate AdvancesToAffiliate	15325000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1138000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	966000	USD
CY2017	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2542000	USD
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4513000	USD
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	16000000	USD
CY2017Q4	us-gaap	Assets Assets	176464000	USD
CY2018Q4	us-gaap	Assets Assets	145737000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	33608000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	48827000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20751000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7700000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7703000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	45700000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28394000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27087000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8203000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1307000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-18884000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	3200000	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	83333000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21573000	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	2157000	USD
CY2017Q4	us-gaap	Cost Method Investments CostMethodInvestments	4096000	USD
CY2018Q4	us-gaap	Cost Method Investments CostMethodInvestments	15771000	USD
CY2017	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	10800000	USD
CY2018	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	12400000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	69751000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Equity Method Investments DeferredTaxAssetsEquityMethodInvestments	60951000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	130436000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	131254000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	299500000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	17100000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	282443000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	967000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1034000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	58138000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	62901000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	814000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	550000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	766000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	675000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	130436000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	131254000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	400000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	200000	USD
CY2018	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.05
CY2018	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	1
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	322000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	692000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.08
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.43
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.34
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.21
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.56
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.81
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.76
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.08
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.43
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.34
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.56
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.81
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.76
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.584
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.195
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.932
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.002
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.015
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.000
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.000
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3321000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3433000	USD
CY2018	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	12600000	USD
CY2017Q4	us-gaap	Equity Method Investments EquityMethodInvestments	108089000	USD
CY2018Q4	us-gaap	Equity Method Investments EquityMethodInvestments	64489000	USD
CY2017	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2018	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2017	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-12000	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4947000	USD
CY2017Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4486000	USD
CY2017Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3758000	USD
CY2017Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3940000	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	17131000	USD
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5589000	USD
CY2018Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5148000	USD
CY2018Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3516000	USD
CY2018Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2618000	USD
CY2018	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16871000	USD
CY2018Q4	us-gaap	Guarantee Obligations Maximum Exposure GuaranteeObligationsMaximumExposure	3800000	USD
CY2017Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	4452000	USD
CY2018Q4	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	37955000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-22097000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-29097000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18650000	USD
CY2017Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-18728000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-88572000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6170000	USD
CY2018Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24896000	USD
CY2018Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	32060000	USD
CY2018Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16623000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15629000	USD
CY2017Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-17002000	USD
CY2017Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-23497000	USD
CY2017Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12874000	USD
CY2017Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-12985000	USD
CY2017	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-66358000	USD
CY2018Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2746000	USD
CY2018Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14540000	USD
CY2018Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	39246000	USD
CY2018Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-7791000	USD
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	19661000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3560000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2065000	USD
CY2017	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	628000	USD
CY2018	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-21000	USD
CY2017Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1198000	USD
CY2017Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	2112000	USD
CY2017Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	2643000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.10
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	2667000	USD
CY2017	us-gaap	Interest Expense Debt InterestExpenseDebt	8620000	USD
CY2018Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2690000	USD
CY2018Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3422000	USD
CY2018Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	3310000	USD
CY2018Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	6645000	USD
CY2018	us-gaap	Interest Expense Debt InterestExpenseDebt	16067000	USD
CY2016	us-gaap	Interest Paid InterestPaid	5000000	USD
CY2018	us-gaap	Interest Paid InterestPaid	11100000	USD
CY2017Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	801000	USD
CY2017Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	1087000	USD
CY2017Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	1004000	USD
CY2017Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	984000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	3876000	USD
CY2018Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	798000	USD
CY2018Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	666000	USD
CY2018Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	718000	USD
CY2018Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	624000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	2806000	USD
CY2017Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	134691000	USD
CY2018Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	95585000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	94668000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	78758000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	176464000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	145737000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	45812000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	32940000	USD
CY2017Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2018Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	22100000	USD
CY2018Q4	us-gaap	Long Term Debt LongTermDebt	68600000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	40485000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2017Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	45321000	USD
CY2018Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	43014000	USD
CY2018Q4	us-gaap	Marketable Securities MarketableSecurities	38000000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29625000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-24952000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10127000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	32103000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20805000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26035000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4947000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4486000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3758000	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	600000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	316000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	517000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4644000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2669000	USD
CY2017	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	0	USD
CY2018	us-gaap	Proceeds From Collection Of Advance To Affiliate ProceedsFromCollectionOfAdvanceToAffiliate	10730000	USD
CY2017	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	16604000	USD
CY2018	us-gaap	Proceeds From Divestiture Of Businesses And Interests In Affiliates ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates	67387000	USD
CY2017Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-3940000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-17131000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5589000	USD
CY2018Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5148000	USD
CY2018Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3516000	USD
CY2018Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2618000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-16871000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4454000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	605000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	602000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	598000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	603000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	2046000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	500000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-88254000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-15516000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3535000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2804000	USD
CY2017	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-339000	USD
CY2018	us-gaap	Other Nonoperating Gains Losses OtherNonoperatingGainsLosses	-2032000	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	249000	USD
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-89000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-379000	USD
CY2017Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-120000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-339000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1435000	USD
CY2018Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2452000	USD
CY2018Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1078000	USD
CY2018Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-193000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5158000	USD
CY2017	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	22867000	USD
CY2018	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	13104000	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5696000	USD
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	2252000	USD
CY2017	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1000	USD
CY2018	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	223000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	267000	USD
CY2017	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	15101000	USD
CY2018	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	3250000	USD
CY2017	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
CY2018	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	37809000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	-22097000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	-29097000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	-18650000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	-18728000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	-88572000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	-6170000	USD
CY2018Q2	us-gaap	Profit Loss ProfitLoss	-24896000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	32060000	USD
CY2017	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	50000000	USD
CY2018	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	35000000	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	17100000	USD
CY2016	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2018	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
CY2017	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	11237000	USD
CY2018	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	8148000	USD
CY2017	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1000	USD
CY2018Q4	us-gaap	Profit Loss ProfitLoss	-16623000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-15629000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1513000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	808000	USD
CY2001Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	26500000	USD
CY2017	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	14455000	USD
CY2018	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	41000000	USD
CY2017	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2018	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	16433000	USD
CY2017Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2018Q4	us-gaap	Restricted Cash RestrictedCash	500000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6336000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2017Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	USD
CY2018Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-715476000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-731105000	USD
CY2018Q1	us-gaap	Severance Costs1 SeveranceCosts1	3900000	USD
CY2018	us-gaap	Severance Costs1 SeveranceCosts1	2800000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	1138000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	966000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	100000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.36
CY2016	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	9.83
CY2018	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	9.83
CY2016	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	19.95
CY2018	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	19.95
CY2017	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2018	us-gaap	State And Local Income Tax Expense Benefit Continuing Operations StateAndLocalIncomeTaxExpenseBenefitContinuingOperations	0	USD
CY2017	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-38000	USD
CY2018	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-267000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-1000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	169777000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	81796000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	66979000	USD
CY2017Q4	us-gaap	Trading Securities TradingSecurities	3761000	USD
CY2018Q4	us-gaap	Trading Securities TradingSecurities	0	USD
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	999000	shares
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	914000	shares
CY2017Q4	us-gaap	Treasury Stock Value TreasuryStockValue	17308000	USD
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	15001000	USD
CY2017	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2018	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-4541000	USD
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20430000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20544000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20430000	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20544000	shares
CY2018	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounting Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates. These estimates include the evaluation of the recoverability of the Company’s ownership interests in and advances to partner companies, the fair value of the credit facility repayment feature derivative, the current portion of the credit facility debt, the recoverability of deferred tax assets, stock-based compensation and commitments and contingencies. Management evaluates its estimates on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts recorded to reflect the Company’s share of income or losses of partner companies accounted for under the equity method are based on unaudited results of operations of those companies and may require adjustments in the future when audits of these entities’ financial statements are completed. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is reasonably possible that the Company’s accounting estimates with respect to the ultimate recoverability of the carrying value of the Company’s ownership interests in and advances to partner companies could change in the near term and that the effect of such changes on the financial statements could be material. At December 31, </font><font style="font-family:inherit;font-size:10pt;">2018</font><font style="font-family:inherit;font-size:10pt;">, the Company believes the carrying value of the Company’s ownership interests in and advances to partner companies is not impaired, although there can be no assurance that the Company’s future results will confirm this assessment, that a significant write-down or write-off will not be required in the future or that a significant loss will not be recorded in the future upon the sale of a company.</font></div></div>

Files In Submission

Name	View Source	Status
0000086115-19-000005-index-headers.html	Edgar Link	pending
0000086115-19-000005-index.html	Edgar Link	pending
0000086115-19-000005.txt	Edgar Link	pending
0000086115-19-000005-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sfe-20181231.xml	Edgar Link	completed
sfe-20181231.xsd	Edgar Link	pending
sfe-20181231_cal.xml	Edgar Link	unprocessable
sfe-20181231_def.xml	Edgar Link	unprocessable
sfe-20181231_lab.xml	Edgar Link	unprocessable
sfe-20181231_pre.xml	Edgar Link	unprocessable
sfe201810k.htm	Edgar Link	pending
sfe201810kex107.htm	Edgar Link	pending
sfe201810kex141.htm	Edgar Link	pending
sfe201810kex211.htm	Edgar Link	pending
sfe201810kex231.htm	Edgar Link	pending
sfe201810kex311.htm	Edgar Link	pending
sfe201810kex312.htm	Edgar Link	pending
sfe201810kex321.htm	Edgar Link	pending
sfe201810kex322.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes

2018 Q4 Form 10-K Financial Statement

#000008611519000005 Filed on March 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES SAFEGUARD SCIENTIFICS INC Stock $sfes

2018 Q4 Form 10-K Financial Statement

#000008611519000005 Filed on March 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SFES
SAFEGUARD SCIENTIFICS INC Stock $sfes